Application of mesenchymal stem cell therapy for the treatment of osteoarthritis of the knee: A concise review

• 作者: Ai-Tong Wang Hao Yu Hong-Hong Jia Meng Zhao Ying Feng
• 来源期刊: 世界干细胞杂志:英文版(电子版)
• 学科: 医学
• 关键词: OSTEOARTHRITIS MESENCHYMAL STEM cells STEM cell THERAPY CLINICAL trials
• 年，卷（期）: 2019,（4）
• 页码范围: 222-235
• 页数: 14页
• 分类号: R

摘要

Osteoarthritis (OA) refers to a chronic joint disease characterized by degenerative changes of articular cartilage and secondary bone hyperplasia. Since articular cartilage has a special structure, namely the absence of blood vessels as well as the low conversion rate of chondrocytes in the cartilage matrix, the treatment faces numerous clinical challenges. Traditional OA treatment (e.g., arthroscopic debridement, microfracture, autologous or allogeneic cartilage transplantation, chondrocyte transplantation) is primarily symptomatic treatment and pain management, which cannot contribute to regenerating degenerated cartilage or reducing joint inflammation. Also, the generated mixed fibrous cartilage tissue is not the same as natural hyaline cartilage. Mesenchymal stem cells (MSCs) have turned into the most extensively explored new therapeutic drugs in cell-based OA treatment as a result of their ability to differentiate into chondrocytes and their immunomodulatory properties. In this study, the preliminary results of preclinical (OA animal model)/clinical trials regarding the effects of MSCs on cartilage repair of knee joints are briefly summarized, which lay a solid application basis for more and deeper clinical studies on cell-based OA treatment.